Patent Information

Overview of filings covering agent-native risk intelligence methods, architectures, and user experiences. This page explains the status, scope, permitted use of notices, and licensing routes.

Status Contact

Status

Applications filed, examination pending. Disclosures controlled. Partner access available under NDA.

Jurisdictions

UKIPO, with PCT route for international protection. National phases planned in EU and US subject to counsel.

Notice

"Patent Pending" provides market notice, deters copying, and signals potential grant of rights.

1. Patent pending status

  • Filed applications cover methods, algorithms, architectures, and UI workflows.
  • Focus on agent-native risk intelligence stack and component interactions.
  • Claim scope may change during prosecution, rights accrue on grant.

Official details can be shared under NDA for diligence. Until grant, notices operate as public warning, not enforceable rights.

2. Proprietary scope covered

Methods and engines

  • ■ Risk Appetite Calculator translation, board statements to operational metrics and capital limits.
  • ■ Balance Module utility allocation across portfolios and initiatives.
  • ■ Scenario and stress engines for scalable simulation across capital, cyber, and operations.

Architectures and UI

  • ■ Agent First Enterprise with context sharing across retrievers, planners, verifiers, and adversarial agents.
  • ■ Decision guardrails and delegations matrix with authority controls and auditability.
  • ■ Interactive report builder and scorecards linking board oversight to front line decisions.

Illustrative only. Precise claims are defined in the filings and may be refined during examination.

3. Use of "Patent Pending" notice

Permitted display

Product UIs, module splash screens, documentation, websites, sales and investor materials.

Effect

Public notice to deter copying, signalling pending examination and potential grant.

Limits

No guarantee of grant, no automatic damages until grant per applicable law, claim scope may change.

4. Guidance for customers and partners

  • Use is licensed through subscription agreements or partner terms only.
  • No right or interest in any patent is granted except as expressly set out in writing.
  • Reverse engineering, replication, or reimplementation is prohibited without consent.
  • Integrations and extensions must use approved methods and interface contracts.

5. Enforcement and protection

Market monitoring will identify potential infringement or misappropriation. On grant, RiskMetrica may pursue injunctions, damages, and other remedies.

Collaborative licensing models are available. Qualified partners and investors can access additional information under NDA.

6. Common questions

What does Patent Pending mean for users?
Core inventions are filed and under examination. You may use the platform within your licence. Copying or reimplementation outside the licence is prohibited.
Will you share claim scope publicly?
Limited details will be public while prosecution is ongoing. Specifics may be shared under NDA for diligence, procurement, or investment.
Can partners license the inventions?
Yes, via partner programmes and enterprise agreements. Contact IP and Legal for permitted fields of use and integration requirements.

7. Contact

For licensing, collaboration, or diligence requests:

  • IP and Legal Affairs, RiskMetrica Ltd
  • Email: ip@riskmetrica.com
  • Address: 10 Fairway Close, Hertfordshire, Harpenden, United Kingdom, AL5 2NN
  • Phone: +44 7807780284

This page is informational, not legal advice. Further information can be provided under NDA. Notices may appear in product UIs and documentation where applicable.